Medical and Pharmaceutical Minnesota’s Vocxi Health and Forj Medical report success with lung cancer breath test It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease Rowan DunneMarch 3, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation The FDA grants Breakthrough Device status to a limited group of technologies Joseph MortonFebruary 19, 2026
Medical and Pharmaceutical Chinese researchers reveal optical sensor for early lung cancer detection The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation Joseph MortonFebruary 17, 2026
Medical and Pharmaceutical BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test Northstar Select already identifies genetic mutations in advanced solid tumors through a blood sample Joseph MortonFebruary 12, 2026
Medical and Pharmaceutical Biotech operator Personalis sees 10% spike from Medicare covering lung cancer blood test The ctDNA blood draw is known for its ultrasensitive detection capabilities Rowan DunneFebruary 10, 2026
Medical and Pharmaceutical Oregon State nanomaterial eradicates breast cancer tumours in mice In mouse experiments using human breast cancer tumors, the results were striking Joseph MortonFebruary 10, 2026
Medical and Pharmaceutical European Lung Cancer Screening Alliance to launch this month News of the upcoming debut came the day before World Cancer Day, Feb. 4 Rowan DunneFebruary 4, 2026
Medical and Pharmaceutical Nearly four in ten global cancer cases are preventable, WHO analysis finds Researchers at the International Agency for Research on Cancer examined data from 185 countries to quantify preventable cancer risk Joseph MortonFebruary 4, 2026
Medical and Pharmaceutical Chinese authorities approve new lung cancer screening blood draw It has demonstrated exceptional early-stage detection capabilities Rowan DunneFebruary 3, 2026